NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Durham's home-grown Humacyte becomes a public company today, as it prepares for final FDA approval of its unique bioengineered human tissue replacement systems.
When a car parts manufacturing company decided to move its 300 Lee County jobs out of its Nash Street factory to a factory in Saltillo, Mexico, Lee County bought the Sanford site for more CCCC workforce training.
Seqirus hopes to raise the bar on flu prevention with the accelerated development of its next-generation vaccine technology, called self-amplifying messenger RNA – or sa-mRNA
Federal and local grants totaling $300,000 are enabling a new pharmaceutical manufacturing workforce training program at Durham Technical Community College.
Thermo Fisher Scientific continues its run on the annual IndustryWeek Best Plants Award with the selection of its Greenville pharmaceutical manufacturing site as the 2021 winner.
Tara Cameron decided she wanted to transition from her career as a certified nursing assistant into a new position in the medical field, so she turned to Wake Tech’s BioWork certificate program and now loves her career as a technician at pharmaceutical manufacturer FUJIFILM Diosynth Biotechnologies in Morrisville.
Metrics Contract Services, a full-service global contract development and manufacturing organization (CDMO) based in Greenville, has expanded its facilities for producing oral, solid-dose drugs.
A $441,028 grant from the National Science Foundation will help a group of educational institutions in the Piedmont Triad prepare a skilled workforce for jobs in regenerative medicine.
Global biopharmaceutical icon Amgen Inc. is building a $550 million manufacturing facility in Holly Springs that will employ 355 people
Seqirus, the global vaccine maker with a mega factory in Holly Springs, has just begun to ship its portfolio of seasonal flu vaccines to healthcare providers across the United States. It is prepared to supply approximately 60 million doses to meet demand for the 2021-2022 flu season.
Bluebird bio, a Massachusetts-based gene and cell therapy company with operations in North Carolina, will sell its Durham biomanufacturing plant to National Resilience for $110 million as part of a strategic alliance between the two companies.
If you're interested in a life sciences career, mark your calendar for Wednesday, August 4 when BioNetwork hosts its fifth virtual career fair in partnership with biopharmaceutical and life sciences companies from across the state.
North Carolina has one of the largest biopharma manufacturing industries in the nation, and a well-coordinated workforce development network is providing the right stuff to keep it growing.
Kriya Therapeutics is poised to revolutionize gene therapies for highly serious diseases like diabetes and severe obesity after landing a whopping $100 million in capital.
Jellatech is a Raleigh startup that is developing a process producing the same collagen that comes from animals --without using any animals.
scroll back to top of page